Claire Langrish

Claire Langrish

Company: Principia Biopharma

Job title: Vice President – Immunology & Biology


Claire Langrish is the Vice President, Immunology and Biology, at Principia Biopharma. She is focused on the translation of drug and disease mechanisms, to discover and develop innovative therapies for immune-mediated diseases. During her post-doc at DNAX, Claire identified the key role of IL-23 in autoimmunity, and discovered Th17 cells, resulting in a dramatic shift in the field of immunology. Since then, she has held positions of increasing responsibility at DNAX, Roche, Takeda and Theravance. Claire received Ph.D. in Immunology from the Great Ormond Street Institute of Child Health, University College London, and a B.Sc. in Biochemistry from Imperial College London. 


Live Q&A 1:00 pm

Using this opportunity to ask your expert speakers those burning questions.Read more

day: Day Two

BTK Mechanism in B Cells and Beyond; Therapeutic Implications for the Treatment of Immune-Mediated Diseases 11:30 am

Expression and role of BTK beyond B-cells Key mechanisms of action of BTK for targeting underlying drivers of immunemediated diseases Relating breadth of BTK pharmacology as it relates to the treatment of immunemediated diseasesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.